

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
ʻO Valoctocogene roxaparvovec kahi lāʻau lapaʻau gene i hoʻolālā ʻia e mālama i ka hemophilia A koʻikoʻi, kahi maʻi koko laha ʻole. Hana kēia lapaʻau hoʻokahi manawa ma ka hāʻawi ʻana i kahi kope hana o ka gene e hana ai i ka factor VIII, kahi protein clotting koko koʻikoʻi i ka poʻe me ka hemophilia A ʻaʻole i loaʻa a i ʻole i nā mea lawa ʻole.
Hōʻike kēia lāʻau lapaʻau hou i kahi holomua nui no ka poʻe e noho nei me ka hemophilia A koʻikoʻi. Ma kahi o ka pono e hoʻokomo mau i ka factor VIII i ko lākou ola a pau, hiki i nā maʻi ke loaʻa ka hana factor VIII mau mai kahi kau lapaʻau hoʻokahi.
ʻO Valoctocogene roxaparvovec kahi lāʻau lapaʻau gene e hoʻohana ana i kahi maʻi i hoʻololi ʻia e hāʻawi i nā ʻōlelo aʻoaʻo genetic i kāu mau cell ate. Hoʻolālā kūikawā ʻia ka lapaʻau no nā mākua me ka hemophilia A koʻikoʻi i hoʻomohala i nā mea pale i nā lāʻau lapaʻau factor VIII kuʻuna a i ʻole e koi i nā hoʻokomo factor VIII pinepine.
Hana ka lāʻau lapaʻau ma ka hoʻolauna ʻana i kahi gene hana e kuhikuhi ana i kou ate e hana i ka protein factor VIII. Lawe ʻia kēia gene e kahi maʻi adeno-associated virus (AAV) i hoʻololi kūikawā ʻia e hana ana ma ke ʻano he kaʻa lawe, e lawe palekana ana i nā mea genetic i kāu mau cell ate kahi e hiki ai ke hoʻomaka e hana i ka clotting factor nalowale.
ʻAʻole like me nā lāʻau lapaʻau hemophilia kuʻuna e koi ana i nā hoʻokomo mau, he lapaʻau hoʻokahi manawa kēia i lawelawe ʻia ma o ka hoʻokomo intravenous hoʻokahi. ʻO ka pahuhopu ka hāʻawi ʻana i kou kino i ka hiki ke hana i kāna factor VIII ponoʻī, e hōʻemi ana a i ʻole ka hoʻopau ʻana i ka pono no ka lāʻau lapaʻau pani maʻamau.
Ua ʻae ʻia kēia lapaʻau gene no ka mālama ʻana i nā pākeke me ka hemophilia A koʻikoʻi. Ua hoʻolālā ʻia no ka poʻe nona nā pae hana factor VIII ma lalo o 1% o ka maʻamau, kahi e waiho ai iā lākou i ka pilikia nui no nā hanana koko spontaneous.
He mea maikaʻi loa ka lapaʻau no nā kānaka i hoʻomohala i nā antibodies neutralizing (inhibitors) e kūʻē i nā huahana factor VIII kuʻuna. Hoʻemi kēia mau mea pale i nā lapaʻau maʻamau, e waiho ana i nā maʻi me nā koho liʻiliʻi no ka mālama ʻana i kā lākou maʻi koko.
Hiki i kāu kauka ke ʻōlelo aku i kēia lapaʻau inā pono ʻoe i nā infusions factor VIII pinepine e pale ai i nā hanana koko. Ke manaʻo nei ka lapaʻau e hōʻemi i kou hilinaʻi ʻana i nā infusions maʻamau ma ka hiki ʻana i kou kino ke hana i ka factor VIII maoli, e hoʻomaikaʻi ana i kou maikaʻi o ke ola a me ka hōʻemi ʻana i ka ukana lapaʻau.
Hana kēia lapaʻau gene ma ka hāʻawi ʻana i kahi kope hana o ka gene factor VIII pololei i kāu mau keena ate. Hoʻohana ka lapaʻau i kahi maʻi adeno-associated i hoʻololi ʻia ma ke ʻano he ʻōnaehana hāʻawi, i manaʻo ʻia he ala palekana a maikaʻi hoʻi no ka hāʻawi ʻana i ka gene.
Ke hiki ka maʻi i kou ate, hoʻokuʻu ia i nā ʻōlelo aʻoaʻo genetic no ka hana ʻana i ka protein factor VIII. A laila, hoʻomaka kāu mau keena ate e hana i kēia mea clotting koʻikoʻi, e komo ana i kou kahe koko a kōkua i kou koko e clot maʻamau ke loaʻa nā ʻeha.
Ua manaʻo ʻia ka lapaʻau he lapaʻau ikaika a hiki ke hoʻololi no ka mea e kamaʻilio ana i ke kumu kumu o ka hemophilia A ma mua o ka mālama ʻana i nā hōʻailona. ʻAʻole like me nā infusions factor VIII kuʻuna e hāʻawi ana i ka hoʻomaha manawa, manaʻo ka lapaʻau gene e hāʻawi i ka hana factor VIII lōʻihi mai loko mai o kou kino ponoʻī.
Hoʻomaka maʻamau nā hopena i loko o kekahi mau pule o ka lapaʻau ʻana, me ka piʻi mālie ʻana o nā pae factor VIII i loko o kekahi mau mahina. ʻIke ka hapa nui o nā maʻi i ka hana factor VIII kiʻekiʻe i loko o 6 a 12 mau mahina ma hope o ka loaʻa ʻana o ka lāʻau lapaʻau.
Hāʻawi ʻia ʻo Valoctocogene roxaparvovec ma ke ʻano he infusion intravenous hoʻokahi i loko o kahi hale lapaʻau kūikawā. Pono e hāʻawi ʻia ka lapaʻau e nā poʻe loea mālama ola i ʻike i ka gene therapy a me ka mālama ʻana i ka hemophilia.
Ma mua o kāu lapaʻau ʻana, e hana ʻoe i nā hoʻokolohua piha e hōʻoia ai he moho kūpono ʻoe. Aia kēia i nā hoʻokolohua koko e nānā i kāu hana ate, ke kūlana o ka ʻōnaehana pale, a me nā pae inhibitor factor VIII. E nānā nō hoʻi kāu kauka i nā pale i loaʻa mua i ka maʻi hoʻouna.
Lawe maʻamau ke kaʻina hana infusion i kekahi mau hola a koi i ka nānā pono ʻana i nā manawa a pau. Pono paha ʻoe e noho i loko o ka hale lapaʻau no ka nānā ʻana ma hope o ka lapaʻau ʻana e nānā i nā hopena koke. E hāʻawi kāu hui mālama ola i nā ʻōlelo kikoʻī e pili ana i ka ʻai ʻana, ka inu ʻana, a me nā lāʻau lapaʻau ma mua a ma hope o ke kaʻina hana.
ʻAʻole koi ʻia nā palena meaʻai kūikawā, akā hiki i kāu kauka ke ʻōlelo aku e pale i ka waiʻona a me kekahi mau lāʻau lapaʻau e hiki ke hoʻopilikia i kāu hana ate i ka manawa o ka lapaʻau.
Hoʻolālā ʻia ʻo Valoctocogene roxaparvovec ma ke ʻano he lapaʻau hoʻokahi manawa e manaʻo nei e hāʻawi i nā pōmaikaʻi lōʻihi. ʻAʻole like me nā lapaʻau hemophilia kuʻuna e koi ana i nā infusions e hana nei, hāʻawi ʻia kēia gene therapy hoʻokahi wale nō.
Ua manaʻo ʻia nā hopena o ka lapaʻau e mau loa, me kāu mau cell ate e hoʻomau nei i ka hana ʻana i ka factor VIII no nā makahiki ma hope o ka infusion hoʻokahi. Ua hōʻike nā haʻawina lapaʻau i ka hana factor VIII mau no nā makahiki ma hope o ka lapaʻau ʻana, ʻoiai ke hōʻiliʻili ʻia nei ka ʻikepili lōʻihi.
Akā, pono ʻoe i nā manawa e hele pinepine ai e nānā i kāu mau pae factor VIII a me kou olakino holoʻokoʻa. Kōkua kēia mau nānā ʻana e hōʻoia i ka hana pono ʻana o ka lāʻau lapaʻau a hiki i kāu hui mālama ola ke hoʻoponopono i nā lāʻau lapaʻau hou inā pono.
Pono paha kekahi poʻe maʻi i nā infusions factor VIII i kekahi manawa i ka wā o ke ʻoki ʻana, ka trauma, a i ʻole inā e emi ana nā pae factor VIII i ka manawa. E hana kāu kauka me ʻoe e hoʻomohala i kahi hoʻolālā nānā a me ka mālama pilikino e pili ana i kāu pane pilikino i ka lāʻau lapaʻau.
E like me nā lāʻau lapaʻau a pau, hiki i ka valoctocogene roxaparvovec ke hana i nā hopena ʻaoʻao, ʻoiai ka hapa nui o nā kānaka e ʻae maikaʻi i ka lāʻau lapaʻau. ʻO nā hopena ʻaoʻao maʻamau he maʻalahi a hiki ke mālama ʻia me ka mālama olakino kūpono.
Hiki i ka hoʻomaopopo ʻana i nā hopena ʻaoʻao ke kōkua iā ʻoe e mākaukau a hilinaʻi i kāu hoʻoholo lapaʻau. Eia nā hopena i hōʻike pinepine ʻia e nā maʻi:
Hoʻoponopono maʻamau kēia mau hopena ʻaoʻao maʻamau i loko o kekahi mau lā a i ʻole mau pule ma hope o ka lapaʻau a hiki ke mālama pinepine ʻia me ka mālama kākoʻo a me nā lāʻau lapaʻau.
Pono nā hopena ʻaoʻao koʻikoʻi akā ʻaʻole maʻamau i ka nānā olakino koke. ʻOiai e hana kēia mau mea i kahi pākēneka liʻiliʻi o nā maʻi, he mea nui e ʻike iā lākou:
E nānā pono kāu hui mālama ola iā ʻoe no kēia mau hopena koʻikoʻi a hāʻawi koke i ka lāʻau lapaʻau inā loaʻa lākou. ʻO ka hapa nui o nā maʻi e loaʻa ana nā hopena ʻaoʻao koʻikoʻi e ola piha me ka mālama olakino kūpono.
ʻOiai ke hāʻawi nei kēia gene therapy i ka manaʻolana no ka nui o nā kānaka me ka hemophilia A koʻikoʻi, ʻaʻole kūpono ia no nā mea a pau. Hiki i kekahi mau maʻi olakino a me nā kūlana ke hoʻolilo i ka lāʻau lapaʻau i palekana ʻole a i ʻole ka liʻiliʻi o ka pono.
E loiloi pono kāu kauka i kāu mōʻaukala olakino a me ke kūlana olakino o kēia manawa ma mua o ka ʻōlelo ʻana i kēia lāʻau lapaʻau. Eia nā kumu nui no ke aha e kūpono ʻole ai kēia lāʻau lapaʻau iā ʻoe:
He mea nui nō hoʻi ka makahiki a me ke kūlana olakino holoʻokoʻa i ka hoʻoholo ʻana i ka moho. Ua ʻae ʻia ka lāʻau lapaʻau i kēia manawa no nā pākeke wale nō, a e noʻonoʻo kāu kauka i kou ola a me ka hiki ke ʻae i ka lāʻau lapaʻau.
Inā he hemophilia A maʻalahi a maʻalahi paha kāu, ʻaʻole pono paha kēia gene therapy ikaika no ka mea hiki i nā lāʻau lapaʻau liʻiliʻi ke mālama pono i kou maʻi. E kūkākūkā kāu kauka inā ʻoi aku ka maikaʻi o nā pōmaikaʻi i nā pilikia i kāu kūlana.
Hoʻolaha ʻia ʻo Valoctocogene roxaparvovec ma lalo o ka inoa brand Roctavian. Hoʻohana ʻia kēia inoa brand ma ka honua holoʻokoʻa no ka mana kalepa o kēia gene therapy.
I ka wā e kūkākūkā ana i kēia lapaʻau me kāu hui mālama ola a i ʻole ka hui ʻinikua, e lohe paha ʻoe i ka inoa maʻamau (valoctocogene roxaparvovec) a i ʻole kona inoa inoa (Roctavian). E pili ana nā inoa ʻelua i ka lāʻau lapaʻau like.
Ua hoʻolālā ʻia ka inoa inoa ʻo Roctavian e maʻalahi ke ʻike ʻia ʻoiai e hōʻike ana i ke kuleana o ka lāʻau lapaʻau i ka mālama ʻana i ka hemophilia A. E hoʻohana paha kāu hale kūʻai lāʻau lapaʻau a me nā moʻolelo lapaʻau i ka inoa inoa i ka wā e palapala ana i kāu lapaʻau.
ʻOiai ʻo valoctocogene roxaparvovec e hōʻike ana i kahi koho lapaʻau hou, aia kekahi mau lāʻau lapaʻau ʻē aʻe no ka mālama ʻana i ka hemophilia A koʻikoʻi. Hiki i kāu kauka ke kōkua iā ʻoe e hoʻomaopopo i ke koho e hana maikaʻi loa no kāu kūlana kikoʻī.
ʻO ka lāʻau lapaʻau pani factor VIII kuʻuna ka lāʻau lapaʻau maʻamau no ka hapa nui o nā poʻe me ka hemophilia A. Hiki i kēia mau lāʻau lapaʻau ke maikaʻi loa a loaʻa nā huahana factor VIII i loaʻa mai ka plasma a me ka recombinant i hāʻawi ʻia ma o nā infusions maʻamau.
No ka poʻe i hoʻomohala i nā mea pale i ka factor VIII, hiki i nā mea e pale ana e like me nā mea i hoʻāla ʻia i ka prothrombin complex concentrates a i ʻole recombinant factor VIIa ke kōkua i ka mālama ʻana i nā hanana koko. Hana kēia mau lāʻau lapaʻau ma ka pale ʻana i ka pono no ka factor VIII i ke kaʻina hana clotting.
Hāʻawi nā lāʻau lapaʻau non-factor hou e like me emicizumab i kahi koho ʻē aʻe, ʻoi aku hoʻi no ka poʻe me nā mea pale. Hāʻawi ʻia kēia lāʻau lapaʻau ma ke ʻano he injection subcutaneous a kōkua i ka hoʻihoʻi ʻana i ka hana o ka factor VIII nalowale ma o kahi ʻano ʻokoʻa.
Hiki i kekahi poʻe maʻi ke pōmaikaʻi mai ka lāʻau lapaʻau induction tolerance immune, ka mea e manaʻo nei e hoʻopau i nā mea pale a hoʻihoʻi i ka pane ʻana i nā lāʻau lapaʻau factor VIII. Pono kēia ala i ka lāʻau lapaʻau ikaika i nā mahina a i ʻole nā makahiki akā hiki ke kūleʻa i nā hihia i koho ʻia.
Hāʻawi ʻo Valoctocogene roxaparvovec i nā pōmaikaʻi kūikawā ma luna o nā lapaʻau factor VIII kuʻuna, akā inā he “ʻoi aku ka maikaʻi” e hilinaʻi ana i kou kūlana pilikino a me nā pahuhopu lapaʻau. Loaʻa nā pōmaikaʻi a me nā manaʻo like ʻole i nā ala ʻelua.
ʻO ka pōmaikaʻi nui o ka lāʻau gene, ʻo ia ka maʻalahi a me ka hoʻomaikaʻi ʻana i ke ola. Ma kahi o ka pono e loaʻa i nā infusions maʻamau i nā manawa he nui i kēlā me kēia pule, loaʻa iā ʻoe kahi lapaʻau hoʻokahi e manaʻo ana e hāʻawi i ka hana factor VIII mau. Hiki i kēia ke hōʻemi nui i ka ukana lapaʻau a hoʻomaikaʻi i ka maikaʻi o ke ola.
Eia naʻe, hāʻawi nā lapaʻau factor VIII kuʻuna i ka palekana lōʻihi i hōʻoia ʻia a me ka hiki ke hoʻoponopono i ka dosage e pili ana i kāu mau pono. Loaʻa i kēia mau lapaʻau nā makahiki he nui o ka ʻikepili palekana a hiki ke hoʻololi ʻia inā hoʻololi kou kūlana, e like me ka wā o ke ʻoki a i ʻole ka maʻi.
He mea pono paha ka lāʻau gene inā ua hoʻomohala ʻoe i nā mea pale i nā lapaʻau kuʻuna a i ʻole e hakakā me ka papa manawa infusion pinepine. Eia naʻe, makemake ʻia nā lapaʻau kuʻuna inā he hopohopo kāu e pili ana i ka ʻenehana hou a i ʻole kekahi mau maʻi e hoʻopilikia ai i ka lāʻau gene.
E kōkua kāu kauka iā ʻoe e kaupaona i kēia mau mea e pili ana i kāu mōʻaukala olakino, nā makemake o ke ola, a me nā pahuhopu lapaʻau. ʻO ke koho maikaʻi loa ʻo ia ka mea e mālama palekana a maikaʻi i kou hemophilia i ka wā e kūpono ana i kou mau kūlana pilikino.
ʻAʻole ʻōlelo ʻia ʻo Valoctocogene roxaparvovec no ka poʻe me ka maʻi ate hana a i ʻole ka pōʻino ate nui. No ka mea, ua manaʻo nui ka lāʻau gene i nā cell ate e hana i ka factor VIII, he mea nui ka hana ate olakino no ka palekana a me ka pono.
Ma mua o ka mālama ʻana, e hana kāu kauka i nā hoʻokolohua hana ate piha e hōʻoia i ka hiki i kou ate ke mālama palekana i ka lāʻau. Inā he mau maʻi ate liʻiliʻi kou, hiki nō i kāu kauka ke noʻonoʻo i ka lāʻau lapaʻau akā e nānā pono iā ʻoe. Eia naʻe, ʻo nā kūlana e like me ka hepatitis ikaika, cirrhosis, a i ʻole ka hana ate koʻikoʻi e hōʻole maʻamau i nā maʻi mai ka loaʻa ʻana o kēia lāʻau lapaʻau.
Hoʻohana ʻia ʻo Valoctocogene roxaparvovec ma ke ʻano he mahele hoʻokahi i helu ʻia ma kahi keʻena lapaʻau, e hana ana i ka overdose ulia pōpilikia. Hāʻawi ʻia ka lāʻau lapaʻau e nā poʻe loea mālama ola i hoʻomaʻamaʻa ʻia e hahai i nā protocols koʻikoʻi e hōʻoia i ka loaʻa ʻana o ka nui pololei i kauoha ʻia.
Inā he hopohopo kāu e pili ana i kāu mahele a i ʻole e ʻike i nā hōʻailona i manaʻo ʻole ʻia ma hope o ka lāʻau lapaʻau, e hoʻopili koke i kāu hui mālama ola. Hiki iā lākou ke loiloi i kou kūlana a hāʻawi i ka mālama kūpono. ʻAʻole hiki ke
ʻAʻole pono ʻoe e hooki i kāu lapaʻau hemophilia i kēia manawa me ka ʻole o ke alakaʻi pololei mai kāu hui mālama ola. Ma hope o ka loaʻa ʻana o ka gene therapy, e nānā mau kāu kauka i kāu pae factor VIII e hoʻoholo ai i ka manawa a me ke ʻano e hōʻemi ai i nā lapaʻau kuʻuna.
Hana mālie ka hoʻololi ʻana i loko o kekahi mau mahina i ka wā e piʻi ai kāu pae factor VIII. Hoʻomau ka hapa nui o nā maʻi i kekahi ʻano o ka nānā ʻana a pono paha i nā infusions factor VIII i kekahi manawa i nā wā pilikia e like me ke ʻoki a i ʻole ka trauma. E hana kāu kauka i kahi hoʻolālā pilikino no ka hoʻololi ʻana mai nā lapaʻau maʻamau e pili ana i kāu pane pilikino i ka gene therapy.
I kēia manawa, ua hoʻolālā ʻia ʻo valoctocogene roxaparvovec ma ke ʻano he lapaʻau hoʻokahi manawa, a ʻaʻole ʻōlelo ʻia ka hana hou ʻana. Ma hope o ka loaʻa ʻana o ka gene therapy, hana kou ʻōnaehana pale i nā antibodies e kūʻē i ka maʻi hoʻouna, e pale ana i ka lapaʻau ʻelua mai ka maikaʻi.
Inā emi ka pae factor VIII i ka manawa, e hana kāu kauka me ʻoe e hoʻomohala i nā hoʻolālā hoʻokele ʻē aʻe. Hiki i kēia ke komo i ka hoʻi ʻana i nā lapaʻau factor VIII kuʻuna a i ʻole ka ʻimi ʻana i nā koho therapeutic ʻē aʻe. Ke hana nei ka noiʻi e hoʻomaopopo i ka lōʻihi o ka gene therapy a me nā hoʻolālā hiki ke hana hou ʻia inā pono i ka wā e hiki mai ana.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.